Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.9T | 3.2T | 3.6T | 2.7T |
Cost of revenue | 2.1T | 2.0T | 2.0T | 1.9T |
Gross profit | 751.0B | 1.1T | 1.6T | 770.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 20.0B | 29.3B | 17.2B | 17.1B |
Other operating expenses | 1.3B | -2.5B | -5.5B | -584M |
Operating income | 613.9B | 1.0T | 1.5T | 644.4B |
Non operating interest income | ||||
Income | 181.2B | 197.5B | 161.5B | 150.5B |
Expense | 45.3B | 49.5B | 37.4B | 28.7B |
Other income expense | — | — | — | — |
Pretax income | 753.1B | 935.8B | 1.8T | 697.8B |
Tax provision | 13.3B | 38.0B | 21.0B | 37.0B |
Net income | 739.7B | 897.8B | 1.7T | 660.8B |
Basic EPS | 833 | — | 2.3K | 923 |
Diluted EPS | 722 | — | 1.7K | 645 |
Basic average shares | 888.0M | — | 753.6M | 716.0M |
Diluted average shares | 1.0B | — | 1.0B | 1.0B |
EBITDA | 1.1T | 1.4T | 2.2T | 752.2B |
Net income from continuing op. | 739.7B | 897.8B | 1.7T | 660.8B |
Minority interests | -38M | -87M | 16M | 103M |
Preferred stock dividends | — | — | — | — |